08.07.14
PAREXEL
4Q Revenues: $585.1 million (+11%)
4Q Earnings: $40.1 million (+34%)
FY Revenues: $2.3 billion (+14%)
FY Earnings: $129.1 million (+34%)
Comments: Consolidated service revenue increased 10% in the quarter to $510.6 million, with $385.6 million in Clinical Research Services (CRS), $55.2 million in PAREXEL Consulting (PC), and $69.8 million in PAREXEL Informatics (PI). For the year consolidated service revenue was up 12% to $1.9 billion, with $1.5 billion in CRS, $216.2 million in PC, and $267.9 million in PAREXEL Informatics, Inc.The recent acquisition of the HERON Group contributed approximately $3.8 million in the quarter, and contributed $2.2 million for the fiscal year. Backlog at the end of June 2014 was $5.0 billion, up 9% for the year.
4Q Revenues: $585.1 million (+11%)
4Q Earnings: $40.1 million (+34%)
FY Revenues: $2.3 billion (+14%)
FY Earnings: $129.1 million (+34%)
Comments: Consolidated service revenue increased 10% in the quarter to $510.6 million, with $385.6 million in Clinical Research Services (CRS), $55.2 million in PAREXEL Consulting (PC), and $69.8 million in PAREXEL Informatics (PI). For the year consolidated service revenue was up 12% to $1.9 billion, with $1.5 billion in CRS, $216.2 million in PC, and $267.9 million in PAREXEL Informatics, Inc.The recent acquisition of the HERON Group contributed approximately $3.8 million in the quarter, and contributed $2.2 million for the fiscal year. Backlog at the end of June 2014 was $5.0 billion, up 9% for the year.